Literature DB >> 27846606

Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.

Josephine M Bryant1,2, Dorothy M Grogono2,3, Daniela Rodriguez-Rincon2, Isobel Everall1, Karen P Brown2,3, Pablo Moreno4, Deepshikha Verma5, Emily Hill5, Judith Drijkoningen2, Peter Gilligan6, Charles R Esther6, Peadar G Noone6, Olivia Giddings6, Scott C Bell7,8,9, Rachel Thomson10, Claire E Wainwright8,11, Chris Coulter12, Sushil Pandey12, Michelle E Wood7,8,9, Rebecca E Stockwell7,8, Kay A Ramsay7,8, Laura J Sherrard7, Timothy J Kidd13,14, Nassib Jabbour15,16, Graham R Johnson16, Luke D Knibbs17, Lidia Morawska16, Peter D Sly18, Andrew Jones19, Diana Bilton19, Ian Laurenson20, Michael Ruddy21, Stephen Bourke22, Ian Cjw Bowler23, Stephen J Chapman23, Andrew Clayton24, Mairi Cullen25, Thomas Daniels25, Owen Dempsey26, Miles Denton27, Maya Desai28, Richard J Drew29, Frank Edenborough30, Jason Evans21, Jonathan Folb31, Helen Humphrey32, Barbara Isalska25, Søren Jensen-Fangel33, Bodil Jönsson34, Andrew M Jones25, Terese L Katzenstein35, Troels Lillebaek36, Gordon MacGregor37, Sarah Mayell29, Michael Millar38, Deborah Modha39, Edward F Nash40, Christopher O'Brien22, Deirdre O'Brien41, Chandra Ohri39, Caroline S Pao38, Daniel Peckham28, Felicity Perrin42, Audrey Perry22, Tania Pressler35, Laura Prtak31, Tavs Qvist35, Ali Robb22, Helen Rodgers43, Kirsten Schaffer41, Nadia Shafi3, Jakko van Ingen44, Martin Walshaw45, Danie Watson38, Noreen West46, Joanna Whitehouse40, Charles S Haworth3, Simon R Harris1, Diane Ordway5, Julian Parkhill1, R Andres Floto2,3.   

Abstract

Lung infections with Mycobacterium abscessus, a species of multidrug-resistant nontuberculous mycobacteria, are emerging as an important global threat to individuals with cystic fibrosis (CF), in whom M. abscessus accelerates inflammatory lung damage, leading to increased morbidity and mortality. Previously, M. abscessus was thought to be independently acquired by susceptible individuals from the environment. However, using whole-genome analysis of a global collection of clinical isolates, we show that the majority of M. abscessus infections are acquired through transmission, potentially via fomites and aerosols, of recently emerged dominant circulating clones that have spread globally. We demonstrate that these clones are associated with worse clinical outcomes, show increased virulence in cell-based and mouse infection models, and thus represent an urgent international infection challenge.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2016        PMID: 27846606      PMCID: PMC5142603          DOI: 10.1126/science.aaf8156

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  52 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

3.  Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.

Authors:  Kyeongman Jeon; O Jung Kwon; Nam Yong Lee; Bum-Joon Kim; Yoon-Hoh Kook; Seung-Heon Lee; Young Kil Park; Chang Ki Kim; Won-Jung Koh
Journal:  Am J Respir Crit Care Med       Date:  2009-08-06       Impact factor: 21.405

4.  Characterization of endonuclease III (nth) and endonuclease VIII (nei) mutants of Escherichia coli K-12.

Authors:  Y Saito; F Uraki; S Nakajima; A Asaeda; K Ono; K Kubo; K Yamamoto
Journal:  J Bacteriol       Date:  1997-06       Impact factor: 3.490

5.  Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient.

Authors:  Jennifer L Taylor; Scott M Palmer
Journal:  J Heart Lung Transplant       Date:  2006-07-11       Impact factor: 10.247

6.  Infection prevention and control guideline for cystic fibrosis: 2013 update.

Authors:  Lisa Saiman; Jane D Siegel; John J LiPuma; Rebekah F Brown; Elizabeth A Bryson; Mary Jo Chambers; Veronica S Downer; Jill Fliege; Leslie A Hazle; Manu Jain; Bruce C Marshall; Catherine O'Malley; Suzanne R Pattee; Gail Potter-Bynoe; Siobhan Reid; Karen A Robinson; Kathryn A Sabadosa; H Joel Schmidt; Elizabeth Tullis; Jennifer Webber; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2014-07-01       Impact factor: 3.254

7.  Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis.

Authors:  Bodil E Jönsson; Marita Gilljam; Anders Lindblad; Malin Ridell; Agnes E Wold; Christina Welinder-Olsson
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

8.  Isolation of nontuberculous mycobacteria (NTM) from household water and shower aerosols in patients with pulmonary disease caused by NTM.

Authors:  Rachel Thomson; Carla Tolson; Robyn Carter; Chris Coulter; Flavia Huygens; Megan Hargreaves
Journal:  J Clin Microbiol       Date:  2013-07-10       Impact factor: 5.948

9.  Increased virulence of an epidemic strain of Mycobacterium massiliense in mice.

Authors:  Shaobin Shang; Sara Gibbs; Marcela Henao-Tamayo; Crystal A Shanley; Gerald McDonnell; Rafael Silva Duarte; Diane J Ordway; Mary Jackson
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

10.  Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis.

Authors:  C E Wainwright; M W France; P O'Rourke; S Anuj; T J Kidd; M D Nissen; T P Sloots; C Coulter; Z Ristovski; M Hargreaves; B R Rose; C Harbour; S C Bell; K P Fennelly
Journal:  Thorax       Date:  2009-07-01       Impact factor: 9.139

View more
  174 in total

1.  Whole-Genome Sequencing for Predicting Clarithromycin Resistance in Mycobacterium abscessus.

Authors:  Samuel Lipworth; Natasha Hough; Laura Leach; Marcus Morgan; Katie Jeffery; Monique Andersson; Esther Robinson; E Grace Smith; Derrick Crook; Tim Peto; Timothy Walker
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Comparing the Utilities of Different Multilocus Sequence Typing Schemes for Identifying Outbreak Strains of Mycobacterium abscessus subsp. massiliense.

Authors:  Aristine Cheng; Hsin-Yun Sun; Yi-Tzu Tsai; Shu-Yuan Chang; Un-In Wu; Po-Ren Hsueh; Wang-Huei Sheng; Yee-Chun Chen; Shan-Chwen Chang
Journal:  J Clin Microbiol       Date:  2019-12-23       Impact factor: 5.948

3.  Extremely Low Hit Rate in a Diverse Chemical Drug Screen Targeting Mycobacterium abscessus.

Authors:  Jakob J Malin; Sandra Winter; Edeltraud van Gumpel; Georg Plum; Jan Rybniker
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

4.  Synergistic Efficacy of β-Lactam Combinations against Mycobacterium abscessus Pulmonary Infection in Mice.

Authors:  Elizabeth Story-Roller; Emily C Maggioncalda; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

5.  Rapid Identification of Clinically Relevant Mycobacterium Species by Multicolor Melting Curve Analysis.

Authors:  Ye Xu; Bin Liang; Chen Du; Xueshan Tian; Xingshan Cai; Yanjie Hou; Hui Li; Rongrong Zheng; Junlian Li; Yuqin Liu; Kaili Wang; Muhammad Ammar Athar; Yaoju Tan; Qingge Li
Journal:  J Clin Microbiol       Date:  2019-01-02       Impact factor: 5.948

6.  Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

Authors:  Shelby Daniel-Wayman; Getahun Abate; Daniel L Barber; Luiz E Bermudez; Rhea N Coler; Michael H Cynamon; Charles L Daley; Rebecca M Davidson; Thomas Dick; R Andres Floto; Emily Henkle; Steven M Holland; Mary Jackson; Richard E Lee; Eric L Nuermberger; Kenneth N Olivier; Diane J Ordway; D Rebecca Prevots; James C Sacchettini; Max Salfinger; Christopher M Sassetti; Christine F Sizemore; Kevin L Winthrop; Adrian M Zelazny
Journal:  Am J Respir Crit Care Med       Date:  2019-04-15       Impact factor: 21.405

Review 7.  Mycobacterial biomaterials and resources for researchers.

Authors:  Manzour Hernando Hazbón; Leen Rigouts; Marco Schito; Matthew Ezewudo; Takuji Kudo; Takashi Itoh; Moriya Ohkuma; Katalin Kiss; Linhuan Wu; Juncai Ma; Moriyuki Hamada; Michael Strong; Max Salfinger; Charles L Daley; Jerry A Nick; Jung-Sook Lee; Nalin Rastogi; David Couvin; Raquel Hurtado-Ortiz; Chantal Bizet; Anita Suresh; Timothy Rodwell; Audrey Albertini; Karen A Lacourciere; Ana Deheer-Graham; Sarah Alexander; Julie E Russell; Rebecca Bradford; Marco A Riojas
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

8.  Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.

Authors:  Christian Dupont; Albertus Viljoen; Sangeeta Thomas; Françoise Roquet-Banères; Jean-Louis Herrmann; Kevin Pethe; Laurent Kremer
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

9.  Genomic Analysis of Mycobacterium abscessus Complex Isolates Collected in Ireland between 2006 and 2017.

Authors:  Natalia Redondo; Simone Mok; Lorraine Montgomery; Peter R Flanagan; Eleanor McNamara; Edmond G Smyth; Niamh O'Sullivan; Kirsten Schaffer; Thomas R Rogers; Margaret M Fitzgibbon
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

10.  Antimicrobial Susceptibility and Phylogenetic Relations in a German Cohort Infected with Mycobacterium abscessus.

Authors:  Nils Wetzstein; Thomas A Kohl; Tilman G Schultze; Sönke Andres; Carla Bellinghausen; Christian Hügel; Volkhard A J Kempf; Annette Lehn; Michael Hogardt; Hubert Serve; Maria J G T Vehreschild; Timo Wolf; Stefan Niemann; Florian P Maurer; Thomas A Wichelhaus
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.